[1]
“Generation of a colony of homozygous K18-hACE2 transgenic mice for the evaluation of vaccine and therapeutic candidates against SARS-CoV-2”, FAVET, vol. 20, no. Suppl., pp. 31–39, Mar. 2022, doi: 10.14409/favecv.v20iSuppl..11212.